Montrouge, France, March 14, 2022
DBV Technologies to Present at the Oppenheimer’s 32nd Annual Healthcare Conference
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Dr. Pharis Mohideen, Chief Medical Officer, will present at the Oppenheimer’s 32nd Annual Healthcare Conference on Thursday, March 17th at 10:00 a.m. ET.
Read more at globenewswire.com